These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 29210632)

  • 1. Role of Matrix Metalloproteinases in Degenerative Kidney Disorders.
    Narula S; Tandon C; Tandon S
    Curr Med Chem; 2018; 25(15):1805-1816. PubMed ID: 29210632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of matrix metalloproteinases in renal pathophysiologies.
    Catania JM; Chen G; Parrish AR
    Am J Physiol Renal Physiol; 2007 Mar; 292(3):F905-11. PubMed ID: 17190907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in kidney disease.
    Zakiyanov O; Kalousová M; Zima T; Tesař V
    Adv Clin Chem; 2021; 105():141-212. PubMed ID: 34809827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of matrix metalloproteinases (MMP) and their tissue inhibitors (TIMP) in nephrology].
    Wasilewska A; Taranta-Janusz K; Zoch-Zwierz W; Rybi-Szumińska A; Kołodziejczyk Z
    Przegl Lek; 2009; 66(9):485-90. PubMed ID: 21033407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix Metalloproteinases in Kidney Disease: Role in Pathogenesis and Potential as a Therapeutic Target.
    Parrish AR
    Prog Mol Biol Transl Sci; 2017; 148():31-65. PubMed ID: 28662825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renoprotective effects of berberine through regulation of the MMPs/TIMPs system in streptozocin-induced diabetic nephropathy in rats.
    Ni WJ; Ding HH; Zhou H; Qiu YY; Tang LQ
    Eur J Pharmacol; 2015 Oct; 764():448-456. PubMed ID: 26192633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases: pathways of induction by bioactive molecules.
    Tsuruda T; Costello-Boerrigter LC; Burnett JC
    Heart Fail Rev; 2004 Jan; 9(1):53-61. PubMed ID: 14739768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases in inflammatory pathologies of the horse.
    Clutterbuck AL; Harris P; Allaway D; Mobasheri A
    Vet J; 2010 Jan; 183(1):27-38. PubMed ID: 19022687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian tissue remodeling: role of matrix metalloproteinases and their inhibitors.
    Smith MF; Ricke WA; Bakke LJ; Dow MP; Smith GW
    Mol Cell Endocrinol; 2002 May; 191(1):45-56. PubMed ID: 12044918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of TIMPs in regulation of extracellular matrix proteolysis.
    Arpino V; Brock M; Gill SE
    Matrix Biol; 2015; 44-46():247-54. PubMed ID: 25805621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
    Gueders MM; Foidart JM; Noel A; Cataldo DD
    Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis.
    Shan L; Wang F; Zhai D; Meng X; Liu J; Lv X
    Biomed Pharmacother; 2023 May; 161():114472. PubMed ID: 37002573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis].
    Fink K; Boratyński J
    Postepy Hig Med Dosw (Online); 2012 Sep; 66():609-28. PubMed ID: 23001203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue inhibitor of metalloproteinases (TIMPs) in heart failure.
    Moore L; Fan D; Basu R; Kandalam V; Kassiri Z
    Heart Fail Rev; 2012 Sep; 17(4-5):693-706. PubMed ID: 21717224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Matrix metalloproteinases and their tissue inhibitors].
    Trojanek J
    Postepy Biochem; 2012; 58(3):353-62. PubMed ID: 23373420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and Biological Attributes of Matrix Metalloproteinases.
    Cui N; Hu M; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 147():1-73. PubMed ID: 28413025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay of angiotensin II and angiotensin(1-7) in the regulation of matrix metalloproteinases of human cardiocytes.
    Pan CH; Wen CH; Lin CS
    Exp Physiol; 2008 May; 93(5):599-612. PubMed ID: 18296491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connective tissue remodeling: cross-talk between endothelins and matrix metalloproteinases.
    Abraham D; Ponticos M; Nagase H
    Curr Vasc Pharmacol; 2005 Oct; 3(4):369-79. PubMed ID: 16248781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases and their inhibitors in bone: an overview of regulation and functions.
    Varghese S
    Front Biosci; 2006 Sep; 11():2949-66. PubMed ID: 16720367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIMPs as multifacial proteins.
    Lambert E; Dassé E; Haye B; Petitfrère E
    Crit Rev Oncol Hematol; 2004 Mar; 49(3):187-98. PubMed ID: 15036259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.